Written question asked by Lord Hunt of Kings Heath (Labour) on Tuesday, 29 October 2019, in the House of Lords. It was due for an answer on Tuesday, 12 November 2019. It was answered by Baroness Blackwood of North Oxford (Conservative) on Monday, 4 November 2019 on behalf of the Department of Health and Social Care.
Liothyronine: West Midlands
- Question
-
To ask Her Majesty's Government what assessment they have made, if any, of whether the Birmingham and Solihull Clinical Commissioning Group is following the updated prescribing guidance for liothyronine issued by the South Regional Medicines Optimisation Committee in July; and what action they are taking to ensure the guidance is being followed.
- Answer
-
The Department has not made an assessment and does not have the responsibility to direct clinical commissioning groups on which medicines they can or cannot prescribe.
Secondary information
- Type
- Written question
- Reference
- HL502
- Session
- 2019-19
- Subjects
- Birmingham Prescriptions Solihull Liothyronine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-12-11 16:32:51 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL502
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL502
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL502